Specialty ingredient and formulation provider Gattefossé announced the successful validation of eight ingredients at its Lufkin, Texas facility. These new ingredients include three pharmaceutical excipients and five cosmetic ingredients which have achieved manufacturing equivalency.
“The validation of our first ingredients at our Lufkin facility is a major achievement for our portfolio,” said Ben Blinder, chief operating officer at Gattefossé USA. “Together, these eight excipients provide formulators with reliable solutions to address today’s formulation challenges. By localizing the production of critical lipid-based excipients, we are directly answering our partners’ need for supply chain resilience and dependable domestic sourcing in an increasingly unpredictable global market.”
The following ingredients from Gattefossé’s personal care portfolio were validated:
- Emulium Mellifera MB: Natural oil-in-water emulsifier
- Compritol 888 CG MB: Multifunctional texturing agent
- Emulium Delta MB: Oil-in-water emulsifier with formulation flexibility
- Plurol Diisotearique CG: Oil-in-water emulsifier for makeup and sun care
- LAS MB: Non-ionic surfactant
Gattefossé’s Lufkin facility opened in September 2025 as a dedicated plant for lipid-based excipients. The company designed the plant with the goals of increasing production capacity and reinforcing Gattefossé’s presence in North America.
